VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
+12.86%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
AUM
$158M
AUM Growth
-$7.14M
Cap. Flow
-$21.5M
Cap. Flow %
-13.64%
Top 10 Hldgs %
5.64%
Holding
474
New
40
Increased
153
Reduced
231
Closed
49

Sector Composition

1 Healthcare 22.36%
2 Technology 15.51%
3 Financials 14.54%
4 Industrials 9.65%
5 Energy 8.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ABUS icon
426
Arbutus Biopharma
ABUS
$805M
-40,040
Closed -$81.3K
AJG icon
427
Arthur J. Gallagher & Co
AJG
$76.7B
-3,415
Closed -$778K
ALB icon
428
Albemarle
ALB
$9.6B
-3,459
Closed -$588K
ALDX icon
429
Aldeyra Therapeutics
ALDX
$334M
-9,460
Closed -$63.2K
AMD icon
430
Advanced Micro Devices
AMD
$245B
-6,731
Closed -$692K
ANSS
431
DELISTED
Ansys
ANSS
-2,186
Closed -$650K
ARQT icon
432
Arcutis Biotherapeutics
ARQT
$2.06B
-9,248
Closed -$49.1K
ATAI icon
433
ATAI Life Sciences
ATAI
$980M
-55,554
Closed -$71.7K
ATO icon
434
Atmos Energy
ATO
$26.7B
-6,059
Closed -$642K
AVIR icon
435
Atea Pharmaceuticals
AVIR
$267M
-24,183
Closed -$72.5K
BTAI icon
436
BioXcel Therapeutics
BTAI
$55.2M
-290
Closed -$11.8K
CHWY icon
437
Chewy
CHWY
$17.5B
-21,146
Closed -$386K
DSGN icon
438
Design Therapeutics
DSGN
$367M
-18,313
Closed -$43.2K
ENTA icon
439
Enanta Pharmaceuticals
ENTA
$189M
-12,784
Closed -$143K
ERAS icon
440
Erasca
ERAS
$457M
-36,494
Closed -$71.9K
EWTX icon
441
Edgewise Therapeutics
EWTX
$1.64B
-10,384
Closed -$59.5K
FATE icon
442
Fate Therapeutics
FATE
$116M
-18,216
Closed -$38.6K
FGEN icon
443
FibroGen
FGEN
$48.9M
-241
Closed -$5.21K
GPC icon
444
Genuine Parts
GPC
$19.4B
-4,778
Closed -$690K
HST icon
445
Host Hotels & Resorts
HST
$12B
-42,510
Closed -$683K
HSY icon
446
Hershey
HSY
$37.6B
-3,028
Closed -$606K
IEX icon
447
IDEX
IEX
$12.4B
-3,513
Closed -$731K
KEYS icon
448
Keysight
KEYS
$28.9B
-4,436
Closed -$587K
KOD icon
449
Kodiak Sciences
KOD
$556M
-10,947
Closed -$19.7K
LLYVK icon
450
Liberty Live Group Series C
LLYVK
$8.88B
-437
Closed -$14K